Skip to main content
. 2023 Jun 14;38(4):e20220072. doi: 10.21470/1678-9741-2022-0072

Table 1.

Epidemiologic characteristics of the population.

Variables N=678 (%)
Age* 61.4±10.7
Female sex 209 (30.8)
Hypertension 556 (82)
DM 240 (35.4)
Current smoker 128 (19.8)
COPD 28 (4.1)
Obesity 147 (22.6)
CAD 522 (77)
Recent MI (< 90 days) 214 (31.6)
Ejection fraction ≤ 40% 63 (9.7)
Ejection fraction (%)* 58.3±12.1
Carotid artery disease 216 (41.1)
TIA/stroke 61 (9.1)
TIA/stroke, treatment
Carotid stent 2 (0.3)
Endarterectomy 1 (0.1)
Clinical treatment 58 (8.7)
PAD 42 (6.2)
Creatinine clearance (ml/min)* 71.0±26.4
Hemodialysis 9 (1.3)
Atrial fibrillation 61 (9.0)
Infective endocarditis 25 (3.7)
Symptoms on admission
Stable angina 177 (26.2)
Unstable angina 113 (16.7)
MI 178 (26.3)
Other 161 (23.8)
No symptoms 47 (7.0)
Acute decompensated heart failure 313 (46.3)
Previous cardiac surgery 29 (4.3)
Urgent surgery 361 (53.3)
EuroSCORE 2.0% (1.2%; 4.0%)
Preoperative cardiogenic shock 13 (1.9)
Intra-aortic balloon pump 8 (1.2)
Time waiting surgery (days)† 7.0 (1.12)
Type of procedure
CABG 461 (68.0)
CABG + AVR 39 (5.7)
CABG + MVR 18 (2.6)
AVR 85 (12.5)
MVR 44 (6.5)
AVR + MVR 15 (2.2)
Other procedures 16 (2.4)
Extracorporeal circulation ≥ 110 min 224 (33.8)
Time in extracorporeal circulation* 102.7±35.6
Internal mammary artery graft 484 (71.4)
Venous graft (number)
0 39 (5.7)
1 100 (14.7)
2 241 (35.5)
≥ 3 137 (20.2)
Valve type
Mechanical 76 (11.2)
Biological 128 (18.9)

AVR=aortic valve replacement; CABG=coronary artery bypass grafting; CAD=coronary artery disease; COPD=chronic obstructive pulmonary disease; DM=diabetes mellitus; EuroSCORE=European System for Cardiac Operative Risk Evaluation; MI=myocardial infarction; MVR=mitral valve replacement; PAD=peripheral arterial disease; TIA=transient ischemic attack

*

Mean ± standard deviation

†Median and interquartile range